title: [Mixte community-acquired Legionella pneumophila and Staphylococcus aureus pneumonia].
authors.forename: B
authors.initials: B
authors.lastname: Bouhaja
authors.forename: H
authors.initials: H
authors.lastname: Thabet
authors.forename: L
authors.initials: L
authors.lastname: Slim
authors.forename: F
authors.initials: F
authors.lastname: Aissa
authors.forename: M
authors.initials: M
authors.lastname: Amamou
authors.forename: M
authors.initials: M
authors.lastname: Yacoub
mesh_terms: D000328:Adult; D017714:Community-Acquired Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007877:Legionnaires' Disease / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D015242:Ofloxacin / Q000627:therapeutic use; D011023:Pneumonia, Staphylococcal / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D012293:Rifampin / Q000627:therapeutic use; D013211:Staphylococcus aureus / Q000302:isolation & purification
chemical_list: D015242:Ofloxacin; D012293:Rifampin
vernacular_title: Pneumopathie communautaire mixte à Legionella pneumophila et Staphylococcus aureus.